Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Feb 14:2020:6565396.
doi: 10.1155/2020/6565396. eCollection 2020.

Natural Products and Their Bioactive Compounds: Neuroprotective Potentials against Neurodegenerative Diseases

Affiliations
Review

Natural Products and Their Bioactive Compounds: Neuroprotective Potentials against Neurodegenerative Diseases

Nur Shafika Mohd Sairazi et al. Evid Based Complement Alternat Med. .

Abstract

In recent years, natural products, which originate from plants, animals, and fungi, together with their bioactive compounds have been intensively explored and studied for their therapeutic potentials for various diseases such as cardiovascular, diabetes, hypertension, reproductive, cancer, and neurodegenerative diseases. Neurodegenerative diseases, including Alzheimer's disease, Huntington's disease, Parkinson's disease, and amyotrophic lateral sclerosis are characterized by the progressive dysfunction and loss of neuronal structure and function that resulted in the neuronal cell death. Since the multifactorial pathological mechanisms are associated with neurodegeneration, targeting multiple mechanisms of actions and neuroprotection approach, which involves preventing cell death and restoring the function to damaged neurons, could be promising strategies for the prevention and therapeutic of neurodegenerative diseases. Natural products have emerged as potential neuroprotective agents for the treatment of neurodegenerative diseases. This review focused on the therapeutic potential of natural products and their bioactive compounds to exert a neuroprotective effect on the pathologies of neurodegenerative diseases.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Various types of mechanisms have been associated with the neurodegeneration that implicated in the progression and pathogenesis of neurodegenerative diseases.
Figure 2
Figure 2
The potential therapeutic targets on various mechanisms of neurodegeneration.

Similar articles

Cited by

References

    1. Yildiz-Unal A., Korulu S., Karabay A. Neuroprotective strategies against calpain-mediated neurodegeneration. Neuropsychiatric Disease and Treatment. 2015;11:297–310. doi: 10.2147/ndt.s78226. - DOI - PMC - PubMed
    1. Przedborski S., Vila M., Jackson-Lewis V. Series introduction: neurodegeneration: what is it and where are we? Journal of Clinical Investigation. 2003;111(1):3–10. doi: 10.1172/jci200317522. - DOI - PMC - PubMed
    1. Gao H.-M., Hong J.-S. Why neurodegenerative diseases are progressive: uncontrolled inflammation drives disease progression. Trends in Immunology. 2008;29(8):357–365. doi: 10.1016/j.it.2008.05.002. - DOI - PMC - PubMed
    1. Allan S. M., Rothwell N. J. Cytokines and acute neurodegeneration. Nature Reviews Neuroscience. 2001;2(10):734–744. doi: 10.1038/35094583. - DOI - PubMed
    1. Mehta A., Prabhakar M., Kumar P., Deshmukh R., Sharma P. L. Excitotoxicity: bridge to various triggers in neurodegenerative disorders. European Journal of Pharmacology. 2013;698(1–3):6–18. doi: 10.1016/j.ejphar.2012.10.032. - DOI - PubMed

LinkOut - more resources